Tumor necrosis factor (TNF) enhances the locomotion of low-density human tonsillar B lymphocytes through the selective triggering of type II receptor.

Corcione, A; Ottonello, L; Tortolina, G; Tasso, P; Ghiotto, F; Airoldi, I; D'Agostino, R; Dallegri, F; Pistoia, V

Corcione, A; Ottonello, L; Tortolina, G; Tasso, P; Ghiotto, F; Airoldi, I; D'Agostino, R; Dallegri, F; Pistoia, V.

Affiliation

Corcione A; Laboratory of Oncology, Scientific Institute G. Gaslini, Genova, Italy.

Ann N Y Acad Sci ; 815: 364-6, 1997 Apr 05.

Article in En | MEDLINE | ID: mdl-9186680

Subject(s)

Adenosine Triphosphatases; B-Lymphocytes/cytology; Cell Movement/drug effects; Palatine Tonsil/cytology; Receptors, Tumor Necrosis Factor/metabolism; Tumor Necrosis Factor-alpha/pharmacology; Antigens, CD/metabolism; Apyrase; Flow Cytometry; Humans; Immunoglobulin D/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Palatine Tonsil / B-Lymphocytes / Cell Movement / Tumor Necrosis Factor-alpha / Adenosine Triphosphatases / Receptors, Tumor Necrosis Factor Limits: Humans Language: En Journal: Ann N Y Acad Sci Year: 1997 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links